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Background: Focal ground-glass opacity (GGO) on thin-section computed tomography (CT) may be seen in
atypical adenomatous hyperplasia (AAH), adenocarcinoma in situ that has recently been renamed from
bronchioloalveolar carcinoma (BAC) and various benign conditions.
Case presentation: We report a case of pulmonary focal fibrosis associated with microscopic arterio-venous fistula
(AVF), which showed a focal area of GGO on thin-section CT. The patient was a 58-year-old woman with a GGO on
thin-section CT which had increased in size over the period of 2 years. Slightly dilated vessels and thickened
interlobular septa were also noted around the GGO. It was diagnosed preoperatively as adenocarcinoma in situ and
a partial lung resection by video-assisted thoracic surgery (VATS) was performed. Pathological examination yielded a
diagnosis of focal fibrosis associated with microscopic AVF.
Conclusion: We speculate that the focal fibrosis was produced by a prolonged congestion due to the AVF and that
the dilated vessels and thickening of interlobular septa on thin-section CT related to the AVF. Microscopic AVF may
be one of the etiologies of focal fibrosis showing focal GGO on thins-section CT. Dilated vessels and thickened
interlobular septa around the GGO might offer a clue to the diagnosis of this disease entity. In addition, it should
be noted that focal fibrosis may increase in size.
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Recently, widespread use of computed tomography (CT)
for lung cancer screening allows us to detect many faint
peripheral pulmonary lesions. Radiologists have come to
encounter focal ground-glass opacity (GGO) more fre-
quently than before. Persistent focal GGO is most com-
monly seen in atypical adenomatous hyperplasia (AAH)
and adenocarcinoma in situ that has recently been
renamed from bronchioloalveolar carcinoma (BAC) in
the revised classification [1]. Focal GGO may also be
seen in various benign conditions, including focal fibro-
sis, focal inflammation, or hemorrhage [2,3]. Focal* Correspondence: nonnon07@hotmail.co.jp
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reproduction in any medium, provided the orfibrosis accounts for approximately 15% of focal pure
GGO [4]. However its etiology is still unknown.
Herein, we present a case of focal fibrosis associated
with microscopic arterio-venous fistula (AVF) manifest-
ing as focal GGO mimicking adenocarcinoma in situ on
chest CT, which suggested a pathogenesis of focal
fibrosis.Case presentation
A 58-year-old woman was referred to our hospital for
detailed evaluation of focal GGO that had been discov-
ered by a screening CT two years before. Thirteen years
earlier, the patient had undergone a partial left lung re-
section for pulmonary hamartoma. Biochemical tests
and tumor markers for lung cancer on admission were
within the normal ranges. Her physical condition was
good with no clinical symptoms. She had never smoked.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Chest thin-section CT on admission to our hospital. (a) A thin-section CT at the level of right upper lobe shows a 10-mm round,
well-defined GGO nodule (arrow). There are slightly dilated veins or thickening of the interlobular septa (arrow heads). (b) Similar findings are
seen also on the slice just above the focal GGO (arrow heads).
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http://www.biomedcentral.com/1471-2466/13/3Chest thin-section CT scan showed a 10-mm pure GGO
with a well-defined and smooth margin in the right
upper lobe (Figure 1a). In addition, slightly dilated veins
and thickening of interlobular septa were seen around
the focal GGO (Figure 1a, b).
The focal GGO was identifiable also on the previous
CT for lung cancer screening when viewed retrospect-
ively (Figure 2). It had increased in size for 2 years. The
lesion was not identified on chest radiograph. Adenocar-
cinoma in situ was considered likely due to the presence
of an interval increase of the GGO. The lesion was
resected by video-assisted thoracic surgery (VATS). It
was unidentifiable during the surgery. HistopathologicalFigure 2 Screening chest CT at 2 years before CT examination
at our hospital. A 7mm slice thickness CT shows a faint pure GGO
in the right upper lobe (arrow), which is smaller than that of
Figure 1.examination of the resected lung tissue revealed no evi-
dence of malignancy but abnormally dilated arterioles,
venules and lymph ducts with an area of peripheral focal
fibrosis consisting of congestion, fibrotic septal thicken-
ing with preservation of the intraalveolar airspaces
(Figure 3a–c). This focal fibrosis was considered to cor-
respond to the focal GGO on thin-section CT. The
dilated arterioles had thickened walls and were directly
communicating with the venules (Figure 3c). These
histopathological findings were similar to those of ar-
teriovenous malformation (AVM). However, the present
case showed no significant evidence of nidus and it was
unknown whether these vascular abnormalities were
congenital or not. Therefore, we regarded it as micro-
scopic AVF.
Discussion
Pure GGO that is persistently (either no change or an
increase in diameter for ≧1 month) present on serial
thin-section CT scans suggests the possibility of AAH,
adenocarcinoma in situ, pulmonary lymphoproliferative
disorder, or organizing pneumonia/focal fibrosis [5]. The
most common diseases showing persistent focal GGO
are AAH and adenocarcinoma in situ. Focal fibrosis is a
relatively rare disease entity constituting 15–21% of per-
sistent focal GGO [3,4].
The pathogenesis of focal fibrosis is still not well
understood. It may represent a focal tissue response to
local lung injury due to infection or radiation, drug, or
physical pressure [6]. In our case, microscopic AVF
coexisted with the focal fibrosis. We speculate that pro-
longed localized congestion caused by AVF lead to focal
tissue fibrosis. Of note in our case is that the focal fibrosis
had increased in size during the time interval between the
two CT examinations. As congestion associated with AVF
is considered a chronic pathophysiological process, the fi-
brosis may have gradually extended.
Figure 3 Histopathology of the resected lung tissue. (a) Photomicrograph (hematoxylin-eosin stain; original magnification, ×2) shows a focal
area of alveolar wall thickening with preservation of the intraalveolar airspaces, consistent with the focal GGO on thin-section CT (arrow). Partial
collapse of this lesion is due to an artifact during the process of specimen production. (b) Photomicrograph (hematoxylin-eosin stain; original
magnification, ×10) shows alveolar wall thickening with fibrosis, and congestion(arrows). Alveolar bronchiolizations are also seen (arrowheads). (c)
Photomicrograph (elastica Masson stain; original magnification, ×4) near the focal fibrosis shows dilated arterioles (asterisk) with markedly
thickened walls, one of which have resulted in luminal obliteration (black arrow), as well as dilated venules (white arrows). A transition from
arteriolar wall to venular one is seen, suggesting a direct communication between them (arrow head).
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cated nodular GGO with a maximal diameter of less
than 2 cm on thin-section CT [4]. Solid components
which pathologically correspond to compact fibrotic foci
or alveolar collapse may be present. These imaging fea-
tures are shared by both focal fibrosis and AAH/ adeno-
carcinoma in situ. Therefore, the differentiation between
these lesions by CT images is difficult. One possible dis-
criminating feature may be that focal fibrosis does not
increase in size over a considerable period of time [6].
However, our case showed an interval growth over a few
years.
F-18 fluorodeoxyglucose positron emission tomog-
raphy (18F-FDG PET) has increasingly been used in the
evaluation of lung cancer. It is also useful for differenti-
ating between malignant and benign nodules. However,
as for focal GGO, it has been shown that 18F-FDG PET
has limited value in the evaluation of focal GGOs for de-
termining nodule malignancy and staging in comparison
with solid nodules. Chun et al. [7] reported that in pure
GGOs, both inflammation and malignancy showed an
SUV less than 1.0 and did not show a statistically signifi-
cant difference. Therefore, 18F-FDG PET is consideredto contribute little to the differentiation between adeno-
carcinoma in situ and focal fibrosis.
A well-known imaging feature of pulmonary AVF is
dilatation of the feeding artery and draining vein with a
nodular area where these vessels join. We couldn’t see
such a nodular area in our case probably because the
AVF was microscopic and thus was too small to see on
CT. However, slightly dilated veins and thickened inter-
lobular septa were demonstrated around the focal GGO
on thin-section CT. We think that these findings related
to the AVF and may be a clue to the differentiation be-
tween this disease entity and AAH/adenocarcinoma in
situ.Conclusions
In summary, we presented a rare case of focal fibrosis
associated with microscopic AVF that showed focal
GGO on thin-section CT. To our knowledge, this is the
first report of this disease entity. Although the CT find-
ings are similar to those of AAH/adenocarcinoma in
situ, dilated vessels and thickened interlobular septa
around the GGO might offer a clue to the differential
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http://www.biomedcentral.com/1471-2466/13/3diagnosis. Additionally, it should be noted that focal fi-
brosis may increase in size.
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